DBVTF
Dbv Technologies SA NYSE EURONEXT - EURO$4.26
Mkt Cap $1.3B
52w Low $1.30
92.5% of range
52w High $4.50
P/E (TTM)
-4.1x
EV/EBITDA
—
P/B
7.5x
Debt/Equity
0.0x
ROE
-87.1%
P/FCF
—
RSI (14)
—
ATR (14)
—
Beta
0.45
50d MA
—
200d MA
—
Avg Volume
970.3K
Recent Filings
8-K
Dbv Technologies SA -- 8-K Filing
DBV Technologies announced conditional regulatory approval for VIASKIN Peanut Patch expansion to children ages 4-7, potentially expanding its addressable market and revenue opportunities if full approval is secured.
Apr 30
8-K
Unknown — 8-K Filing
I need more specific information from the 8-K filing to provide meaningful analysis. The excerpt provided only mentions accounting standards, not material events requiring disclosure. Could you share the key event or development disclosed in this 8-K?
Mar 26
Data updated apr 27, 2026 9:27pm
· Source: massive.com